Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM …

JJV McMurray, J Östergren, K Swedberg, CB Granger… - The Lancet, 2003 - thelancet.com
Background Angiotensin II type 1 receptor blockers have favourable effects on
haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when …
被引用次数：2669 相关文章

[引用][C] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the …

JJV McMurray, J Ostergren, K Swedberg, CB Granger… - Lancet, 2003 - eprints.gla.ac.uk
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic
function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial - Enlighten …
[PDF] academia.edu

[PDF][PDF] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the …

JJV McMurray, J Östergren, K Swedberg… - THE LANCET, 2003 - academia.edu
Background Angiotensin II type 1 receptor blockers have favourable effects on
haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when …
[PDF] psu.edu

[PDF][PDF] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the …

JJV McMurray, J Östergren, K Swedberg, CB Granger… - THE LANCET, 2003 - Citeseer
Background Angiotensin II type 1 receptor blockers have favourable effects on
haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when …

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM …

JJV McMurray, J Östergren, K Swedberg, CB Granger… - The Lancet, 2003 - Elsevier
BACKGROUND: Angiotensin II type 1 receptor blockers have favourable effects on
haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when …

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM …

JJV McMurray, J Östergren, K Swedberg, CB Granger… - The Lancet, 2003 - thelancet.com
Background Angiotensin II type 1 receptor blockers have favourable effects on
haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when …

[引用][C] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensinconverting-enzyme inhibitors: the …

M JJ - Lancet, 2003 - cir.nii.ac.jp
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic
function taking angiotensinconverting-enzyme inhibitors : the CHARM-Added trial | CiNii …

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM …

JJV McMurray, J Ostergren, K Swedberg, CB Granger - The Lancet, 2003 - elibrary.ru
The number of deaths from any cause in the candesartan group was 377 (30%) compared
with 412 (32%) in the placebo group (unadjusted 0 [middot] 89 [0 [middot] 77-1 [middot] 02] …

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM …

JJ McMurray, J Ostergren, K Swedberg… - Lancet (London …, 2003 - europepmc.org
Background Angiotensin II type 1 receptor blockers have favourable effects on
haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when …

[引用][C] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The …

JJV MCMURRAY, J ÖSTERGREN… - Lancet (British …, 2003 - pascal-francis.inist.fr
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular
systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial …